MGNX MacroGenics Corp: שולי רווח נקי ממכירות

MacroGenics - לוגו גרפי של המנפיק MGNX

MacroGenics, Inc. is recognized as an expert in developing targeted antibodies for tumor therapy. However, business success is based on clinical trial outcomes, while financial stability depends on partner payments and liquidity. The current net profit margin visualizes these fundamental aspects, where the value of -46.60 reflects the balance of the profitability metric for each unit of revenue.

שיעור רווח נקי MacroGenics, Inc. (MGNX): לתקופה 04.07.2022 - 19.11.2026

פילוחי מדדים ואנליטיקה של חברת MacroGenics Corp (MGNX)

- שער מניה ותחזית מחירי מומחים:
ניתוח מקיף של החברה:MacroGenics, Inc.
סחורת הדגל של MacroGenics Inc

Sales margin determines the share of net profit in every dollar of revenue, reflecting overall cost management efficiency. A decline in this ratio amid rising revenues signals bloating operating expenses and a risk to capital. By analyzing the depth of the sales margin, an investor sees the current value of -46.60. For MacroGenics, Inc. (MGNX), this metric depends on the cost of strict biologics logistics. Optimizing the laboratory network directly impacts final profitability.